Liliana Aline Fernández-Urrutia has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Digital Health Communication and Vaccine Confidence in Mexico Using Aggregated Randomized Brand Lift Studies: Secondary Analysis

    by Berenice Muñoz Cordero, Rodrigo Romero Feregrino, Raúl Romero Cabello, Valeria Magali Rocha Rocha, Roberto Martinez-Medina, Liliana Aline Fernández Urrutia

    Background: Digital vaccination campaigns are increasingly used to address declining vaccine confidence, yet evidence from large-scale, real-world interventions in middle-income countries is limited. Meta’s Brand Lift Studies (BLS), which use randomized test-control exposure, provide Bayesian estimates of attitudinal shifts resulting from digital content. Mexico, with over 88.6 million active internet users, provides a setting to evaluate the impact of targeted campaigns on vaccine attitudes. Objective: This study evaluated the impact of 5 digital vaccination campaigns implemented by the Asociación Mexicana de Vacunología (@Vacunologia) on Facebook (Meta Platforms Inc) and Instagram (Meta Platforms Inc) in Mexico between 2021 and 2022 on key attitudinal constructs related to COVID-19 vaccine confidence. Methods: This study used a retrospective ecological design. We analyzed aggregated BLS results for 5 campaigns targeting different audiences and vaccination themes. Measured outcomes included standard ad recall, perceived importance, perceived safety, perceived efficacy, and concerns about side effects. Statistical significance within the BLS framework was defined as an incremental lift of ≥2 percentage points with ≥90% posterior probability of replication—a threshold consistent with Meta’s operational Bayesian approach. Exploratory comparisons across campaigns were conducted using 1-way ANOVA, unpaired 2-tailed t tests, and Fisher exact tests. Results: Campaigns reached 84.9 million accounts and generated 179.4 million impressions with a total investment of US $215,600. All campaigns produced statistically significant improvements in at least one attitudinal outcome (Bayesian threshold ≥90%). Standard ad recall increased in 4 campaigns (ANOVA, P <.001), and concerns about side effects decreased in 2 campaigns ( t test, P =.049; P =.006). Perceived safety, importance, and efficacy improved in selected audiences, with stronger effects observed among younger users and women (ANOVA, P =.005). No direct behavioral outcomes (eg, vaccination uptake) were measured; therefore, the findings reflect attitudinal rather than behavioral change. However, these constructs are recognized as proximal predictors of vaccine decision-making and constitute health-related outcomes. Conclusions: Large-scale digital vaccination campaigns can meaningfully strengthen attitudinal determinants of vaccine confidence in a middle-income context. These social media advertising campaigns effectively increased standard ad recall and improved perceptions of vaccine importance and safety, particularly among younger audiences and women in urban areas. However, changes in efficacy perceptions and concerns about side effects were limited. The innovation and implications of this study lie in evaluating large-scale, real-world digital vaccine campaigns in Latin America using experimental BLS data. Findings highlight that audience segmentation yields stronger perceptual shifts, suggesting that tailored digital strategies can complement traditional public health communication. While the BLS does not measure behavioral end points, the observed attitudinal improvements represent foundational steps toward influencing vaccine-related behaviors. Future work should link digital attitudinal metrics with vaccination and epidemiological data to assess real-world health impact.

  • Open Access

    The Two-Gasometry Indirect Fick Method: An Inconsistent Method for Measuring Cardiac Output in Critical Patients

    by Daniela Cuellar-Mendoza, Javier Mancilla-Galindo, Esmeralda Garza-Santiago, Liliana Aline Fernandez-Urrutia, Gabriela Alejandra Bautista-Aguilar, Ashuin Kammar-García, Ernesto Deloya-Tomas, Orlando Ruben Perez-Nieto

    Background: The two-gasometry indirect Fick method (iFM) is commonly applied to estimate cardiac output (CO) and cardiac index (CI) in low-resource settings. Validation against other accessible methods such as transthoracic echocardiography (TTE) is lacking. Objective: To determine agreement and clinical interchangeability of CO and CI measurements from TTE (reference test) and two-gasometry iFM (index test) in critical care patients from a low-resource hospital. Methods: Cross-sectional study including critical patients. CO and CI were measured by intensive care medicine residents with TTE (3 per patient-event) and the two-gasometry iFM (1 per patient-event). Agreement was evaluated using mean absolute difference, linear mixed-effects models, and Bland-Altman analysis for repeated measures with 95% limits of agreement (LoA). Precision, bias, and variability were quantified with coefficients of variation, error, and least significant change (LSC), with 95% confidence intervals (95%CI) using bootstrapping. Results: A total 243 measurements were performed across 81 time points in 52 participants. Bland-Altman analysis and linear mixed-effects models revealed poor correlation for both CO (ICC = 0.09) and CI (ICC = -0.09). The mean bias between TTE and iFM was -1.59 L/min (95 LoA: -8.1 to 4.92) for CO and -1 L/min/m2 (95% LoA: -4.8 to 2.8) for CI. The mean absolute percentage error of the two-gasometry iFM method compared to TTE was 57.5% (95%CI: 45.5 to 74.6). The LSC was 11.9% for TTE and 80.4% for two-gasometry iFM. Conclusions: The two-gasometry indirect Fick method performs poorly compared to TTE and should not be used for decision making in critical patients.

  • Open Access

    Statistical Considerations for the Design and Analysis of Pragmatic Trials in Aging Research

    by Ashuin Kammar-García, Liliana Aline Fernández-Urrutia, Jorge Alberto Guevara-Díaz, Javier Mancilla-Galindo

    Pragmatic trials aim to assess intervention efficacy in usual patient care settings, contrasting with explanatory trials conducted under controlled conditions. In aging research, pragmatic trials are important designs for obtaining real-world evidence in elderly populations, which are often underrepresented in trials. In this review, we discuss statistical considerations from a frequentist approach for the design and analysis of pragmatic trials. When choosing the dependent variable, it is essential to use an outcome that is highly relevant to usual medical care while also providing sufficient statistical power. Besides traditionally used binary outcomes, ordinal outcomes can provide pragmatic answers with gains in statistical power. Cluster randomization requires careful consideration of sample size calculation and analysis methods, especially regarding missing data and outcome variables. Mixed effects models and generalized estimating equations (GEEs) are recommended for analysis to account for center effects, with tools available for sample size estimation. Multi-arm studies pose challenges in sample size calculation, requiring adjustment for design effects and consideration of multiple comparison correction methods. Secondary analyses are common but require caution due to the risk of reduced statistical power and false-discovery rates. Safety data collection methods should balance pragmatism and data quality. Overall, understanding statistical considerations is crucial for designing rigorous pragmatic trials that evaluate interventions in elderly populations under real-world conditions. In conclusion, this review focuses on various statistical topics of interest to those designing a pragmatic clinical trial, with consideration of aspects of relevance in the aging research field.


  • Open Access

    Statistical Considerations for the Design and Analysis of Pragmatic Trials in Aging Research

    by Ashuin Kammar-García, Liliana Aline Fernández-Urrutia, Jorge Alberto Guevara-Díaz, Javier Mancilla-Galindo

    Pragmatic trials aim to assess intervention efficacy in usual patient care settings, contrasting with explanatory trials conducted under controlled conditions. In aging research, pragmatic trials are important designs for obtaining real-world evidence in elderly populations, which are often underrepresented in trials. In this review, we discuss statistical considerations from a frequentist approach for the design and analysis of pragmatic trials. When choosing the dependent variable, it is essential to use an outcome that is highly relevant to usual medical care while also providing sufficient statistical power. Besides traditionally used binary outcomes, ordinal outcomes can provide pragmatic answers with gains in statistical power. Cluster randomization requires careful consideration of sample size calculation and analysis methods, especially regarding missing data and outcome variables. Mixed effects models and generalized estimating equations (GEEs) are recommended for analysis to account for center effects, with tools available for sample size estimation. Multi-arm studies pose challenges in sample size calculation, requiring adjustment for design effects and consideration of multiple comparison correction methods. Secondary analyses are common but require caution due to the risk of reduced statistical power and false-discovery rates. Safety data collection methods should balance pragmatism and data quality. Overall, understanding statistical considerations is crucial for designing rigorous pragmatic trials that evaluate interventions in elderly populations under real-world conditions. In conclusion, this review focuses on various statistical topics of interest to those designing a pragmatic clinical trial, with consideration of aspects of relevance in the aging research field.

  • Open Access

    Body Composition and Metabolic Consequences of Most Frequent Antibiotics Given to Newborns in Intensive Care Units, an Experimental Study in Newborn Rats

    by Enrique Segura-Cervantes, Javier Mancilla-Ramírez, Liliana Fernández-Urrutia, Susana González-Gallardo, Lourdes Mendoza-Gertrudis, Jasibe Valencia-Santaella, Norma Galindo-Sevilla

    Introduction: Overuse of antibiotics has been increasing in recent years and is currently the most prescribed drug in the paediatric age. It is estimated that 72% of patients in the neonatal intensive care unit (NICU) are treated with antibiotics. One of the effects observed with their use is the alteration of the microbiota, which is associated with metabolic disorders including obesity. In this study, the aim was to determine in newborn rats, whether most commonly prescribed antibiotics in Mexican NICUs have a differential effect on weight gain, development of adiposity, and modification of carbohydrate and lipid metabolism. Methods: This is an experimental study in newborn rats, comparing Ampicillin/Meropenem (Access/Watch groups) 100 mg/g every 12 h /10 mg/g every 12 h (each of these two antibiotics was adjusted to the required dosages based on weight); Cefotaxime 200 mg/g every 24 h; (Watch group) and Amikacin 15 mg/g every 24 h (Access group) versus Saline Solution as Control. Each antibiotic was intraperitoneal administered daily for 5 days in males (to avoid gender differences) to 14 newborn rats in each group. A comparison of anthropometric and biochemical parameters registered on day 28 was made using ANOVA analysis. Differences were considered if p < 0.05.Results: Amikacin was the antibiotic with the greatest effect on anthropometric measurements and LDL-cholesterol; as well as Cefotaxime on Glucose and triglycerides, while Meropenem plus Ampicillin showed the weakest effect on measured parameters. Conclusion: The administration of antibiotics in the neonatal stage has repercussions on the body composition of adult rats, as well as on lipids and carbohydrates serum levels. Future studies might evaluate the toxicity of antibiotics on the immature neonatal organs.